Venture Catalyst Hosts Fourth Annual Biotech Innovation Gallery Event and Startup Showcase |
|
The virtual Biotech Innovation Gallery (BIG) Event and Startup Showcase on January 6, 2022 marked the culmination of the Venture Catalyst BIG Accelerator program, which supports a cohort of early stage biotech startups associated with UC Davis by providing targeted mentoring engagements, business model and investor pitch coaching, guidance on fundraising strategy, and assistance with developing marketing collateral used when engaging with potential investors and strategic partners. Eight of the startups that participated in the BIG Accelerator program were selected to deliver elevator pitches during the main showcase including:
-
Histolix promises the next generational of rapid slide-free tissue imaging and decision-support tools that address critical needs in cancer care and medical diagnostics. The technology provides real-time results at half the cost of conventional approaches.
-
Eunicera is developing novel therapeutics to treat and cure advanced drug-resistant recurrent prostate cancer.
-
Mirnova leverages cancer elements to develop small molecules and microRNA drugs for treatment of neurological disorders, such as stroke, traumatic brain injury, as well as SARS-CoV-2 associated brain injury.
-
Async Health has developed an app focusing on Asynchronous Telepsychiatry with a patient facing interface that will allow patients to audio and video self-record as they are automatically interviewed via a decision tree series of questions.
-
Molecular Matrix is developing an innovative platform technology for tissue regeneration applications. Osteopoietic Systems™ is their first clinical solution to the need for value-driven and safe bone regeneration products.
-
Matrubials is developing therapeutics from mammalian milk to combat severe bacterial infections and modern diseases with an initial focus on women’s health.
-
VGN BIO is developing viral protein-derived peptide drugs that only selectively kills cancer cells, while keeping normal cells intact. The developed peptide complexes with the MYC gene leading to cancer cell death.
-
Kibio has developed new small molecule inhibitors of galectin-1 with in vivo efficacy and tolerability for malignant peripheral nerve sheath tumor (MPNST) and prostate cancer.
The event also included an overview of investing trends in the life sciences and academic spinouts and featured a a keynote talk from Kirsten Leute, Partner, University Relations at Osage University Partners.
-
Learn more about the presenting Startups Click here
-
Reach Venture Catalyst to be connected to presenting startups or learn more about our investor and strategic partner engagement initiatives...Contact
|
|
UC Davis Researchers Developing Novel Cancer Drug That Mimics Viral Mechanisms
|
|
The Venture Catalyst STAIR Proof-of-Concept awardee, Yoshi Izumiya, professor of Viral and Pathogens Associated Malignancies Initiative at the UC Davis Comprehensive Cancer Center, previous STAIR Proof-of-Concept awardee, Michiko Shimoda, assistant professor in the Department of Dermatology founded VGN BIO to research and develop a lead with an indication for cancer and autoimmune diseases. The drug candidate is a viral protein-derived peptide with a MYC gene payload that selectively reduces cancer cells in mouse models. These awardees used the STAIR program's translational research funding and mentorship services to advance towards commercialization.
|
|
UC Davis Office of Research Annual Report |
|
Research at UC Davis unlocks insight and solutions that empower a more resilient society. Our research programs address a diverse range of needs, often bringing together experts from multiple disciplines to collaborate on groundbreaking discoveries for some of the most complex challenges that we face. |
|
SBDCtech is offering the National Science Foundation's Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Virtual Workshop. This is a free opportunity for businesses to tap into non-dilutive federal funding to conduct research and development on promising new innovations and technologies.
Virtual Workshop:
February 3, 2022
1:00PM - 3:00PM
|
|
Seed Central Innovators Showcase |
|
Seed Central, in cooperation with Venture Catalyst, the UC Davis Innovation Institute for Food & Health, and the Microbiome Special Research Program will host a virtual Innovators Showcase with pitch sessions, panel discussions, and online company visits scheduled for Thursday, January 27, 2022. The showcase will feature startups and innovative companies in seed, ag, agbiotech, microbiome, and food & health.
|
|
UC Davis CoLab Taps AWS to Accelerate Digital Health Innovation, with an Eye Toward Health Equity
|
|
UC Davis Health Digital CoLab launches the first Cloud Innovation Center based at a academic medical center in partnership with Amazon Web Services (AWS). This open innovation program addresses problems within digital healthcare operations by launching challenges among healthcare institutions and addressing feedback from the community. |
|
Venture Catalyst Welcomes the
New Marketing and Outreach Manager
|
|
|
|
UC Davis Venture Catalyst is pleased to announce that Spencer Hamilton has joined the team as the Marketing Research and Outreach Manager, supporting technology startups, managing market research and competitive analysis programs and outreach to the innovation ecosystem. Spencer brings experience in market research and technology commercialization to his team. He holds an MBA and BA degrees from Johns Hopkins University and University of Southern California, respectively. In his spare time, he enjoys nature and immersions in foreign countries.
|
|
New Ways to Detect COVID-19 |
|
UC Davis engineers Cristina Davis and Heather Bischel are using their respective expertise to develop new ways to detect COVID-19. Davis is developing a portable breathalyzer-like device that rapidly diagnoses COVID-19 and tells doctors how severe the case is going to be. Bischel is using wastewater to detect the virus, follow viral trends across the City of Davis and the UC Davis campus and help prevent outbreaks. Both methods are poised to become staples in the response to COVID-19 and future pandemics.
|
|
Science Translational and Innovative Research (STAIRTM) grant and mentorship is coming soon.
The grant announcement will be published on January 27, 2022.
Grant Application deadline is March 17, 2022.
|
Little Bang! Poster + Pitch Competitions sponsored by the Mike and Renee Child Institute for Innovation and Entrepreneurship is an entry level event that helps you define your business idea and communicate it concisely on a poster.
|
Big Bang! Connect. Learn. Compete. sponsored by the Mike and Renee Child Institute for Innovation and Entrepreneurship is a business competition designed for aspiring and early-stage entrepreneurs.
Application Deadlines:
Early Feedback Round (January 19, 2022)
Round 1 (February 10, 2022)
Round 2 (March 10, 2022)
Round 3 (April 27, 2022)
|
Skydeck offers an 6-month acceleration program for promising startups in any vertical who are affiliated with UC Berkeley, any UC campus, Lawrence Berkeley Lab, or global founders.
Batch 14 Application Period: Reopen in February 2022 .. Learn more
|
CITRIS Foundry Incubator helps innovators and entrepreneurs bridge the gap from lab to market and actualize rigorous, validated solutions to society’s biggest challenges.
|
MedTech Accelerator & Competition is the largest accelerator of medical technology companies.
Application Deadline: January 31, 2022... Learn more
|
IndieBio Accelerator aims to turn scientists into entrepreneurs who can save lives and save the planet.
|
Educational Opportunities |
UC Davis Institute for Innovation & Entrepreneurship Ideas into Actions Workshops
|
Registration is open for this event (Date: March 11-12, 2022)... Learn more
|
Regional Educational Opportunities |
Sacramento Entrepreneurship Academy
|
Sacramento State Carlsen Center for Innovation & Entrepreneurship
|
Small Business Development Center Workshops... Learn more
|
California Life Sciences Institute FAST Advisory Program... Learn more
|
Bay Area NSF Innovation Corps Immersive Short Course... Learn more
|
World AgriTech Innovation Summit
|
Startup Grind Global Conference
|
|
About Venture Catalyst
UC Davis Venture Catalyst supports the development of new ventures fueled by university research and technology. Venture Catalyst offers several innovative programs that bridge the gap between early-stage research and commercialization and provide entrepreneurs the resources, support, and connections needed to successfully form and grow technology-based startups. With a focus on accelerating technology-led economic development in the Davis-Sacramento region, Venture Catalyst also works closely with partners in the regional innovation and economic development ecosystems.
Contact Venture Catalyst
For more information or for editorial comments, please email us.
|
|
|
|
|
|
|
